Skip to main content

Table 1 Characteristics of women treated for osteoporosis at the time of the consultation (questionnaire population; N = 785).

From: Compliance and treatment satisfaction of post menopausal women treated for osteoporosis. Compliance with osteoporosis treatment

Patient characteristics   Treatments  
Age (years) 66.30 ± 9.07 Daily bisphosphonates 17 (2.2%)
Age at menopause (years) 49.75 ± 3.97 Weekly bisphosphonates 305 (40.6%)
Time since menopause (years) 16.49 ± 9.38 Monthly bisphosphonates 202 (26.9%)
Densitometry in the last six months 667 (85.3%) SERMs 76 (10.1%)
Osteoporotic fractures 389 (51.7%) Strontium ranelate 119 (15.8%)
At least one risk factor 618 (78.7%) Others 26 (3.5%)
  1. Data are presented as mean ± SD for quantitative variables and as numbers of women (%) for categorical variables. Data were missing for up to six patients for certain variables. SERM: selective oestrogen receptor modulators. 'Others' include parathyroid hormone analogues and hormone substitution therapy.